About Emphasys Medical
Emphasys Medical is a company based in Redwood City (United States) founded in 2000 was acquired by Pulmonx in May 2009.. Emphasys Medical has raised $68.4 million across 3 funding rounds from investors including Morgan Stanley, Pulmonx and Orbimed. Emphasys Medical operates in a competitive market with competitors including Pulmonx, Spiration, Neurent Medical, Gradient Denervation Technologies and Uptake Medical, among others.
- Headquarter Redwood City, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Emphasys Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$68.4 M (USD)
in 3 rounds
-
Latest Funding Round
$18.4 M (USD), Series E
Jul 27, 2006
-
Investors
Morgan Stanley
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Pulmonx
(May 13, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Emphasys Medical
Emphasys Medical has successfully raised a total of $68.4M across 3 strategic funding rounds. The most recent funding activity was a Series E round of $18.4 million completed in July 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series E — $18.4M
-
First Round
First Round
(01 Jan 2003)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2006 | Amount | Series E - Emphasys Medical | Valuation |
investors |
|
| Jun, 2004 | Amount | Series B - Emphasys Medical | Valuation |
investors |
|
| Jan, 2003 | Amount | Series A - Emphasys Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Emphasys Medical
Emphasys Medical has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Morgan Stanley, Pulmonx and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
VC firm making investment in early stage startups in the US
|
Founded Year | Domain | Location | |
|
Venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Emphasys Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Emphasys Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Emphasys Medical Comparisons
Competitors of Emphasys Medical
Emphasys Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, Spiration, Neurent Medical, Gradient Denervation Technologies and Uptake Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of smart devices for treating pulmonary diseases
|
|
| domain | founded_year | HQ Location |
IntraBronchial Valve to treat lung disease
|
|
| domain | founded_year | HQ Location |
Smart devices for minimally invasive rhinitis treatment are developed.
|
|
| domain | founded_year | HQ Location |
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
|
|
| domain | founded_year | HQ Location |
Targeted vapor therapy is developed for endoscopic lung volume reduction.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Emphasys Medical
When was Emphasys Medical founded?
Emphasys Medical was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Where is Emphasys Medical located?
Emphasys Medical is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Is Emphasys Medical a funded company?
Emphasys Medical is a funded company, having raised a total of $68.4M across 3 funding rounds to date. The company's 1st funding round was a Series A of $21.5M, raised on Jan 01, 2003.
What does Emphasys Medical do?
Endobronchial valves for emphysema treatment were developed by the company, which was founded in 2000 in Redwood City, United States. Operations focus on medical devices in the pulmonology sector. The Zephyr Endobronchial Valve system serves as the primary product, designed to block airflow through lung openings and into the chest cavity. This mechanism reduces or eliminates leaks, enabling tissue healing in affected areas.
Who are the top competitors of Emphasys Medical?
Emphasys Medical's top competitors include Pulmonx, Neurent Medical and Gradient Denervation Technologies.
Who are Emphasys Medical's investors?
Emphasys Medical has 6 investors. Key investors include Morgan Stanley, Pulmonx, Orbimed, Advanced Technology Ventures, and ABS Ventures.